Multicenter phase II study of fixed sequences of capecitabine combined with oxaliplatin or irinotecan in patients with previously untreated metastatic colorectal cancer. [electronic resource]
Producer: 20060706Description: 429-35 p. digitalISSN:- 1533-0028
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Capecitabine
- Colorectal Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Drug-Related Side Effects and Adverse Reactions
- Female
- Fluorouracil -- analogs & derivatives
- Humans
- Irinotecan
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.